Skip to main content

quizartinib

Generic: QUIZARTINIB DIHYDROCHLORIDE·Brand: VANFLYTA, Vanflyta

quizartinib: 2 clinical trials tracked.

quizartinib evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about quizartinib, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Acute Myeloid Leukemia
Clinical Trial Registry Records (2)

Clinical Study of Sonrotoclax Combined With Azacitidine Plus Individualized Targeted Drugs in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia

NCT07548710Registry updated 2026-07-30·Phase 2
Recruiting

Primary endpoint: Composite Complete Remission

Interventionalopen205 targetStarted 2026-05Completion 2028-121 site · ChinaRuijin Hospital

Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination With Ziftomenib or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib for the Treatment of Patients With Acute Myeloid Leukemia

NCT05735184Registry updated 2026-03-13·Phase 1·KURA
Recruiting

Primary endpoint: Rate of dose limiting toxicities (DLTs) per dose level (Part 1a only)

Interventionalopen420 targetStarted 2023-07Completion 2030-0444 sites · United StatesKura Oncology, Inc.